For the Inventor, By the Inventor

Enter assignee name

Durham, NC, United States of America

Chimerix, Inc.

USPTO Granted Patents = 28

% Expired Patents = 17.9

CIPO Patents = 3

EPO Patents = 10

Trademarks = 2

Forward Citations = 479

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Roy Wendell Ware (16 out of 18 patents)

Ernest Randall Lanier, Jr (11 out of 11 patents)

Aaron Leigh Downey (10 out of 11 patents)

4. Merrick R Almond (9 out of 19 patents)

5. John Henry Bougher, Iii (5 out of 5 patents)

6. Andrew Louis McIver (5 out of 9 patents)

7. Bradley David Robertson (5 out of 5 patents)

8. Phiroze Behram Sethna (5 out of 5 patents)

9. Ramamurty V S Changalvala (5 out of 5 patents)

10. Dean Wallace Selleseth (5 out of 5 patents)

11. George R Painter (5 out of 26 patents)

12. John Charles Drach (5 out of 41 patents)

13. Leroy B Townsend (5 out of 44 patents)

14. Karl Y Hostetler (4 out of 73 patents)

15. Bernhard Lampert (4 out of 4 patents)

Core Competencies:

Pyrrolopyrimidine Nucleosides

Phosphonate Esters

Retroviral Infections

Antiviral Compounds

Viral Infections

Ocular Conditions

Poxvirus Infections

Fluorescence Immunoassay

Lipid Derivatives

Antiproliferative Phosphonates

Morphic Forms

Synthesis Methods

28 patents: Sort by Forward Citations

1. 11981700 - Pyrrolopyrimidine nucleosides and analogs thereof (2024-05-14),

2. 11111264 - Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide and uses thereof (2021-09-07),

3. 11066373 - Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof (2021-07-20),

4. 10941175 - Pyrrolopyrimidine nucleosides and analogs thereof (2021-03-09),

5. 10487061 - Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof (2019-11-26),

6. 10407457 - Pyrrolopyrimidine nucleosides and analogs thereof (2019-09-10),

7. 10112909 - Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof (2018-10-30),

8. 9956239 - Methods of treating retroviral infections and related dosage regimes (2018-05-01),

9. 9862687 - Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof (2018-01-09),

10. 9765100 - Nucleoside phosphonate salts (2017-09-19),

11. 9708359 - Pyrrolopyrimidine nucleosides and analogs thereof (2017-07-18),

12. 9701706 - Pyrrolopyrimidine nucleosides and analogs thereof (2017-07-11),

13. 9694024 - Methods of treating retroviral infections and related dosage regimes (2017-07-04),

14. 9371344 - Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof (2016-06-21),

15. 9303051 - Phosphonate ester derivatives and methods of synthesis thereof (2016-04-05),

Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on developing innovative antiviral therapeutics. The company specializes in addressing unmet medical needs in the treatment of viral infections, particularly in immunocompromised patients. Chimerix's research efforts are centered on advancing its proprietary drug candidates and leveraging its expertise in drug development to improve patient outcomes in challenging therapeutic areas.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

28 Patents

#36 in Durham, NC

#269 in North Carolina

#12,009 in US

#23,262 in the World

Durham, NC, United States of America

Chimerix, Inc.

Forward Citations = 479

26 inventors:

Roy Wendell Ware (16 out of 18 patents)

Ernest Randall Lanier, Jr (11 out of 11 patents)

Aaron Leigh Downey (10 out of 11 patents)

4. Merrick R Almond (9 out of 19 patents)

5. John Henry Bougher, Iii (5 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…